edgewisetx.comBioTechFounded: 2017Funding to Date: $65.5MM
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need.
For more details on financing and valuation for Edgewise Therapeutics, register or login.
Already registered? Click here to log in
To read this article and more news on Edgewise Therapeutics, register or login.
Already registered? Click here to log in.
Forge and SharesPost have teamed up to provide you with an enhanced trading experience.